(Q38020430)

27 August 2017

A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome (English)

1 reference

27 August 2017

2

1 reference

27 August 2017

Gerwyn Morris

1

1 reference

27 August 2017

21 June 2012

1 reference

27 August 2017

Metabolic Brain Disease

1 reference

27 August 2017

28

1 reference

27 August 2017

4

1 reference

27 August 2017

523-540

1 reference

https://scigraph.springernature.com/pub.10.1007/s11011-012-9324-8

27 August 2017

0 references

cites work

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Proteomic method identifies proteins nitrated in vivo during inflammatory challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Circumventricular organs: receptive and homeostatic functions and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Proinflammatory cytokines increase the rate of glycolysis and adenosine-5'-triphosphate turnover in cultured rat enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Circulating pyrogen signaling of the brain. A new working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

The NF-kappaB regulatory network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

A formal analysis of cytokine networks in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Myalgic encephalomyelitis: International Consensus Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Fungal strategies for overcoming host innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

In vivo magnetic resonance spectroscopy in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating 31P MRS for measuring brain ATP synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Redox regulation of the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Pollen-induced oxidative stress influences both innate and adaptive immune responses via altering dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Nitrous oxide decreases cortical methionine synthase transiently but produces lasting memory impairment in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Exercise capacity in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

IL-1 resets glucose homeostasis at central levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Acute amygdaloid response to systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Cytokine mRNA expression in patients with multiple sclerosis and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Plasma cytokines in women with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

The T-cell pool is anergized in patients with multiple sclerosis in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Changes in microglial activation within the hindbrain, nodose ganglia, and the spinal cord following subdiaphragmatic vagotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Mechanism and biological significance of CD4-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

A five-year prospective study of fatigue in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Watching the watcher: regulation of p53 by mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Monocyte trafficking in acute and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Foxp3 expression in p53-dependent DNA damage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Superoxide anions induce the maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Next generation tools for the annotation of human SNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic beta-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Microglia in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Role of infection and neurologic dysfunction in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Sleep and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Chronic fatigue syndrome: clinical condition associated with immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning--a comparison of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Myeloneuropathy after prolonged exposure to nitrous oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

p53 regulates mitochondrial respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

TNF-alpha and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Symptoms of autonomic dysfunction in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Chronic fatigue syndrome: exercise performance related to immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Role of Stat3 in regulating p53 expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Biochemical regulation of non-rapid-eye-movement sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Longitudinal MRI shows no cerebral abnormality in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

The impact of systemic infection on the progression of neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Systemic infections and inflammation affect chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Microglia in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Role of outer membrane architecture in immune evasion by Treponema pallidum and Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Microglial physiology: unique stimuli, specialized responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

On the potential role of glutamate transport in mental fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Omega-3 fatty acids in inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Immunological abnormalities in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

21 January 2018

The inflammatory reflex

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Postexertional malaise in women with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

The innate immune response to products of phospholipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Inflammation as a causative factor in the aetiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Autonomic function and serum erythropoietin levels in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Reduction of serotonin transporters of patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Killing me softly: chlamydial use of proteolysis for evading host defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Differentiation of effector CD4 T cell populations (*)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Noninvasive Diagnosis of Mitochondrial Dysfunction in HAART‐Related Hyperlactatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection Effect of parenteral treatment with SAMe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9324-8

Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.

21 January 2018

1 reference

12 December 2020

Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo

1 reference

12 December 2020

TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C.

1 reference

12 December 2020

Brain MR in chronic fatigue syndrome.

1 reference

12 December 2020

Fatigue in multiple sclerosis: current understanding and future directions.

1 reference

12 December 2020

Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS.

1 reference

12 December 2020

Peroxidative damage to cardiac mitochondria: cytochrome oxidase and cardiolipin alterations

1 reference

12 December 2020

Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.

1 reference

12 December 2020

Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins

1 reference

12 December 2020

Vagal activities are involved in antigen-specific immune inflammation in the intestine

1 reference

12 December 2020

Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide

1 reference

12 December 2020

The aerobic forearm exercise test, a non-invasive tool to screen for mitochondrial disorders

1 reference

12 December 2020

Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.

1 reference

12 December 2020

Chronic fatigue syndrome and mitochondrial dysfunction

1 reference

12 December 2020

Interleukin-1β and adverse effects on cerebral blood flow during long-term global hypoperfusion

1 reference

12 December 2020

Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome

1 reference

12 December 2020

Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome

1 reference

12 December 2020

Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta.

1 reference

12 December 2020

Parkinson's disease and systemic inflammation

1 reference

12 December 2020

Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells

1 reference

12 December 2020

Adaptive surface antigen variation in Mycoplasma bovis to the host immune response

1 reference

12 December 2020

Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis

1 reference

12 December 2020

Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: An experimental study

1 reference

12 December 2020

High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders.

1 reference

12 December 2020

Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins.

1 reference

12 December 2020

CD69: an unexpected regulator of TH17 cell-driven inflammatory responses

1 reference

12 December 2020

Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins.

1 reference

12 December 2020

Immunological similarities between cancer and chronic fatigue syndrome: the common link to fatigue?

1 reference

12 December 2020

Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.

1 reference

12 December 2020

Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders

1 reference

12 December 2020

Advanced multiplexed analysis with the FlowMetrix system

1 reference

12 December 2020

In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation

1 reference

12 December 2020

Cytokine measurement in lymphocyte culture supernatant of inactive lepromatous leprosy patients

1 reference

12 December 2020

Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study.

1 reference

12 December 2020

Chronic fatigue syndrome: immune dysfunction, role of pathogens and toxic agents and neurological and cardial changes

1 reference

12 December 2020

Immunologic abnormalities in chronic fatigue syndrome

1 reference

12 December 2020

Free radical scavenging and antioxidant effects of lactate ion: an in vitro study

1 reference

12 December 2020

Delayed kinetics of tumor necrosis factor-mediated bystander lysis by peptide-specific CD8+ cytotoxic T lymphocytes

1 reference

12 December 2020

Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway.

1 reference

12 December 2020

Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse

1 reference

12 December 2020

Management of the patient with IgG subclass deficiency and/or selective antibody deficiency.

1 reference

12 December 2020

Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome

1 reference

12 December 2020

Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus.

1 reference

12 December 2020

Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1.

1 reference

12 December 2020

Variations of IL2, IL6, TNF alpha plasmatic levels in relapsing remitting multiple sclerosis

1 reference

12 December 2020

Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome

1 reference

12 December 2020

The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens

1 reference

12 December 2020

10.1007/S11011-012-9324-8

Identifiers

DOI

1 reference

PubMed ID

22718491

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

22718491